Clinical Trial Recruitment in Autoimmune Disorders

Dec. 12, 2011 - PRLog -- The average patient recruitment per trial per year has continued to decline over the past decade across the five major indications of autoimmune disorders which are multiple sclerosis, rheumatoid arthritis, Crohn’s disease, ulcerative colitis and psoriasis. The average number of patients recruited for clinical trials across five major autoimmune disorders was approximately 408 in 2000. This average had declined to 74 in 2009. In between 2000 and 2009, there is an irregular trend of average patients recruited for clinical trials in five major autoimmune disorders

Most number of clinical trials is conducted for central nervous system followed by oncology. 2,298 trials have been conducted for CNS across the globe and 2,044 trials have been conducted for oncology. The number of clinical trials in autoimmune disorders for the period 2000 to 2009 is less compared to other therapeutic areas. Only 668 trials have been conducted in autoimmune disorders in the period 2000 to 2009.

For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Cli...

GBI Research, the leading business intelligence provider, has released its latest research “Clinical Trial Recruitment in Autoimmune Disorders - Average Patient Recruitment per Trial has Continued to Decline Over the Past Decade” which provides an insight into clinical trial and patient recruitment in Autoimmune Disorders. The report examines different aspects under clinical trial and patient recruitment. The report analyzes the number of clinical trials and the number ofpatients recruited for five major indications such as Multiple Sclerosis, Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis and Psoriasis. It provides information about the total number of clinical trials conducted, by stage of development, geography, major sponsors and trials conducted per year. Analysis on the total number of patients recruited and the average number of patients recruited per each trial is also provided. The report analyzes total number of patients recruited by stage of development, geography, major sponsors and trails conducted per year from 2000 to 2009. The average number of patients recruited by stage of development per year is also covered. For Brazil, China and India, an estimate of prevalence population has also been provided for the years 2010 to 2017 across the five major autoimmune disorders

For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Clinical-Trial-...
Visit our report store: http://www.gbiresearch.com

For more details contact:
pressreleases@gbiresearch.com
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GBI Research is a market-leading provider of business intelligence reports. GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders’ insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs